Bernard Coulie

CIK: 0001808895

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (10.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (52.6%)

Compensation grants

Other (G, F, J, C, D, …)7 (36.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PLRX

PLIANT THERAPEUTICS, INC.

DirectorOfficer

SEPN

Septerna, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (19 total)

PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
256.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
325K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
325K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
256.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
146.8K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
146.8K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
327.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
327.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
250K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
250K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
440K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
440K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
206.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
206.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.2M shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 20, 2026
Sale(S)
Direct
89.4K shares at avg. $1.28$114K
SEPN
Septerna, Inc.
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
16.6K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 23, 2025
Award(A)
Direct
162.5K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 17, 2025
Sale(S)
Direct
52.4K shares at avg. $11.20$587K

		Type	Shares	Price		Ownership
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	256,300	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	325,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	325,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	256,300	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	146,841	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	146,841	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	327,262	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	327,262	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	250,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	250,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	440,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	440,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	206,300	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	206,300	-	-	Direct
Jan 22, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	1,230,000	-	-	Direct
Jan 20, 2026	PLRX PLIANT THERAPEUTICS, INC.	Sale(S)	89,375	$1.28	$114,400	Direct
Jun 17, 2025	SEPN Septerna, Inc.	Award(A) Stock Option (Right to Buy)	16,623	-	-	Direct
Jan 23, 2025	PLRX PLIANT THERAPEUTICS, INC.	Award(A)	162,500	-	$0	Direct
Jan 17, 2025	PLRX PLIANT THERAPEUTICS, INC.	Sale(S)	52,419	$11.20	$587,150	Direct

1-19 of 19 transactions

About Coulie Bernard

Coulie Bernard (SEC CIK 0001808895) files insider reports with the SEC as President and CEO of PLIANT THERAPEUTICS, INC. (PLRX) and Director of Septerna, Inc. (SEPN).

Signal8 holds 7 ownership filings by Coulie Bernard (1 Form 3, 6 Form 4), filed between Oct 24, 2024 and Apr 17, 2026. Those filings report 19 transactions, from Jan 17, 2025 to Apr 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Coulie Bernard's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Coulie Bernard

Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).

Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)

Raben David, Chief Medical Officer
Iannone Robert, Director
Borellini Flavia, Director
CROWELL GAYLE A, Director
MCCOURT Thomas A, Director
Krognes Steve E., Director

How to read Form 4 transaction codes